$100M Alzheimer's Funding Plan Includes Genentech Drug Trial

Law360, New York (May 15, 2012, 3:23 PM EDT) -- Federal health officials on Tuesday said they planned to spend $100 million as part of a national plan to find a cure for Alzheimer's disease, including $15 million of a $100 million clinical trial of a potential treatment created by Roche Holding AG's Genentech Inc. unit.

The U.S. Department of Health and Human Services said $80 million of the $100 million requested in President Barack Obama's 2013 budget would go to Alzheimer's research, including the Genentech trial and $7.9 million towards the clinical trial of an...
To view the full article, register now.